SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention centers on speculation that SELLASs Phase 3 REGAL AML trial is nearing its final event trigger and subsequent topline analysis, with traders reacting to CEO commentary and favorable remarks from pharmaceutical-industry professionals. The community remains sharply divided: bulls view the prolonged survival and outside commentary as supportive, while bears question the trial design, delayed event timing, and likelihood of a successful readout.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Preliminary second-quarter results showing sharply improved operating profitability despite lower revenue, together with an amended convertible-note exchange that limits stock issuance and shifts the remainder to cash, are driving attention. Traders are divided between viewing the developments as evidence of improving fundamentals and reduced dilution risk, and focusing on revenue declines, management concerns, and unusual warrant activity that has fueled speculative squeeze discussion.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Celina, Texass reported conversion of its city WiFi into Helium-powered carrier coverage is driving attention, with traders viewing the deployment and broader carrier-offload use case as evidence of real-world DePIN adoption. Bullish commenters expect continued momentum, while skeptics question token dilution, hotspot profitability, and whether network usage will translate into value for HNT holders.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Anticipation of broader federal marijuana rescheduling to Schedule III, including an upcoming administrative-law recommendation, is driving attention as traders expect reduced tax burdens and improved institutional access for U.S. cannabis operators. The community remains largely bullish on Trulieves positioning and NYSE listing, while others warn that the catalyst is not yet finalized and cite profit-taking, overbought conditions, and post-earnings concerns.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Strong Phase 3 data for CAN-2409 in localized prostate cancer, along with anticipation of ASTRO findings and a planned Q4 BLA submission, is driving bullish attention. Traders see potential regulatory and pharmaceutical-partnership upside, while skeptics point to dilution risk, the unfiled BLA, profit-taking, and broader biotech momentumincluding enthusiasm around cancer-vaccine developmentsas competing factors.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Reports of renewed U.S.-Iran hostilities, tanker attacks, and severely disrupted Strait of Hormuz flows are driving attention to USO, with traders debating whether the supply shock will lift crude prices. The Venezuela oil agreement and possible diplomatic reopening are viewed by bears as longer-term supply relief, while bulls argue infrastructure limits mean they will not quickly offset the disruption.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Escalating Iran and Strait of Hormuz tensions, along with volatile oil prices, are driving attention to Carnival as traders weigh higher fuel costs and travel disruption risks. The community is divided between bearish short-term views tied to geopolitical headlines and bullish investors citing resilient bookings, debt reduction, buybacks, dividends, and perceived undervaluation.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Upcoming quarterly earnings are the dominant catalyst, with traders focused on whether Broadcoms AI custom-chip and networking demand will support stronger guidance. Bulls expect a beat and continued momentum from OpenAI and hyperscaler projects, while bears argue expectations are already elevated and remain concerned about debt, potential Google-related share loss, and another post-earnings selloff.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Positive Phase 3 SHASTA-3 and SHASTA-4 results for plozasiran in severe hypertriglyceridemia, including substantial triglyceride reductions and fewer acute pancreatitis events, are driving attention and expectations for a broader regulatory filing. Traders are broadly bullish on REDEMPLOs commercial potential and Arrowheads RNAi platform, although some debate the valuation, competition from Ionis, and the stocks volatile sell-the-news trading.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Canadian government funding for Xanadus quantum-manufacturing Project OPTIMISM is driving attention, while traders debate whether additional federal and Ontario support will materialize. The community is split between viewing the backing as validation of Xanadus photonic technology and warning that heavy cash burn, limited revenue, and potential dilution could offset the benefit.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HYSTER-YALE DECLARES QUARTERLY DIVIDEND

HYSTER-YALE DECLARES QUARTERLY DIVIDEND HYSTER-YALE DECLARES QUARTERLY DIVIDEND PR Newswire CLEVELAND, Aug. 12, 2026 CLEVELAND, Aug. 12, 2026 /PRNewswire/ -- Hyster-Yale, Inc. (NYSE: HY) announced today that the Board of Directors declared a regular cash dividend of 36.5 cents per share. The...

Hyster-Yale (HY) Reports Q2 Loss, Beats Revenue Estimates

Hyster-Yale (HY) delivered earnings and revenue surprises of +20.00% and +1.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

HYSTER-YALE ANNOUNCES SECOND QUARTER 2026 RESULTS

HYSTER-YALE ANNOUNCES SECOND QUARTER 2026 RESULTS HYSTER-YALE ANNOUNCES SECOND QUARTER 2026 RESULTS PR Newswire CLEVELAND, Aug. 4, 2026 Q2 2026 Consolidated Highlights:Bookings of $680 million represent the fourth consecutive quarter of growth; 17% higher sequentially and twice the level of Q2...

Terex (TEX) Beats Q2 Earnings and Revenue Estimates

Terex (TEX) delivered earnings and revenue surprises of +9.60% and +4.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Hyster-Yale (HY) Fell More Than Broader Market

Hyster-Yale (HY) closed the most recent trading day at $32.15, moving 6.35% from the previous trading session.

HYSTER-YALE ANNOUNCES DATES OF SECOND QUARTER 2026 EARNINGS RELEASE AND WEBCAST

HYSTER-YALE ANNOUNCES DATES OF SECOND QUARTER 2026 EARNINGS RELEASE AND WEBCAST HYSTER-YALE ANNOUNCES DATES OF SECOND QUARTER 2026 EARNINGS RELEASE AND WEBCAST PR Newswire CLEVELAND, July 28, 2026 CLEVELAND, July 28, 2026 /PRNewswire/ -- Hyster-Yale, Inc. (NYSE: HY) announced today it will release...

Hyster-Yale (HY) Stock Moves -1.16%: What You Should Know

Hyster-Yale (HY) reached $33.15 at the closing of the latest trading day, reflecting a -1.16% change compared to its last close.

Why Hyster-Yale (HY) Dipped More Than Broader Market Today

Hyster-Yale (HY) concluded the recent trading session at $33, signifying a -2.14% move from its prior day's close.

Hyster-Yale (HY) Ascends While Market Falls: Some Facts to Note

In the closing of the recent trading day, Hyster-Yale (HY) stood at $33.72, denoting a +1.38% move from the preceding trading day.

Hyster-Yale (HY) Outperforms Broader Market: What You Need to Know

Hyster-Yale (HY) reached $32.68 at the closing of the latest trading day, reflecting a +1.84% change compared to its last close.

• Reported GAAP EPS of -$1.76 down -122.78% YoY
• Reported revenue of $812.9M down -15.02% YoY

Hyster-Yale faced a significant operating loss driven by lower sales volumes, a shift toward lower-priced product mixes, and elevated tariff-related costs that negatively impacted Hyster-Yale's quarterly financial performance results.

Hyster-Yale achieved strong booking growth for four consecutive quarters, reaching a $1.6 billion backlog, while Hyster-Yale also benefited from significant tariff-related recoveries recognized during the second quarter of 2026.

Hyster-Yale, Inc. engages in the manufacture of lift trucks. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), and Japan and Asia Pasific (JAPIC), Bolzoni, and Nuvera. The Americas include the United States, Canada, Mexico, Brazil, Latin America, and the corporate headquarters. The JAPIC segment involves the operations in the Asia and Pacific regions, China, and the equity earnings. The Bolzoni segment focuses on the distribution and production of attachments, forks, and lift tables marketed under the Bolzoni, Auramo, and Meyer brand names. The Nuvera segment consists of design, manufacture, and sale of hydrogen fuel cell stacks and engines. The company was founded in 1999 and is headquartered in Cleveland, OH.

Hyster Yale Inc - Ordinary Shares - Class A

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.59	--	--	N/A
Q2 '26	-$2.20	-$1.76	20.18%	BEAT
Q1 '26	-$2.03	-$1.71	15.56%	BEAT
Q4 '25	-$2.01	-$2.96	-47.63%	MISSED
Q3 '25	-$0.24	-$0.13	45.83%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings